Backgrounds/Aims: Essential nutritional support and nutrition therapy for patients with hepatobiliary and pancreatic diseases undergoing surgery is critical, as it may improve clinical outcome. How to implement rational fluid therapy and nutritional support after surgery and effectively protect organ function is crucial for postoperative recovery. The aim this study was to examine the safety and efficacy of peripheral nutrition fluid (MG-TNA ® ) in patients undergoing surgery for hepatobiliary and pancreatic disease. Methods: All adult patients undergoing surgery for hepatobiliary and pancreatic disease received peripheral nutrition fluid (MG-TNA ® ) on the second postoperative day for 3 days. During administration of parenteral nutrition, patients were closely monitored for adverse effects (primary endpoint). Secondary endpoints included nutritional parameters such as serum prealbumin, transferrin, and creatine kinase (CK) levels. Results: Thirty patients completed the study and were included in the full analysis set. There was no evidence of metabolic complications such as hyperglycemia, azotemia, hypertriglyceridemia, metabolic acidosis and hypokalemia. In addition, there were no adverse effects. There was a significant decrease in serum prealbumin and CK on the third postoperative day (p＜0.0001). Although not statistically significant, serum transferrin levels tended to decrease (p=0.0519). 
INTRODUCTION
Hepatobiliary disease including hepatitis, pancreatitis, cholecystitis, alcoholic liver disease, cirrhosis, hepatocellular carcinoma and pancreatic cancer in East Asia is prevalent and accounts for half of the total global incidence. And 5-20% of them will undergo high risk hepatobiliary surgery each year for both benign and malignant disorders. 1 The liver, gallbladder and pancreas are the main organs of nutritional metabolism, including protein synthesis, glycogen storage, fat digestion and detoxification. These functions become damaged to a greater or lesser extent in patients with diseases, resulting in various metabolic disorders, and their disturbed nutritional condition is associated with disease progression. Most patients present with significant weight loss due to anorexia and malabsorption, and are expected to have a period of inadequate oral intake up to 10 days after surgery. 2, 3 Malnutrition of different degrees will occur in at least more than half of these patients. 4 Therefore, essential nutritional support and nutrition therapy for patients with hepatobiliary and pancreatic diseases undergoing surgery is very important, as it may improve clinical outcome. 5, 6 However, considering the nutrient metabolism abnormalities during the perioperative pe- riod, the nutritional support and fluid therapy could become complex. How to implement rational fluid therapy and nutritional support after surgery and effectively protect organ function is crucial for postoperative recovery. 7 Perioperative nutrition is a well recognized aspect of care in recent years and has been shown to reduce the incidence of complications and to reduce hospital stay. 8 Although clinical research has shown that early delivery of nutrition via the gastrointestinal tract after severe injury can reduce septic morbidity and mortality in critically in- Sample size calculation and statistical analyses Since this study was a single arm study to examine the safety and efficacy of a parenteral nutrition solution, a specific sample was not calculated. Instead, we decided to enroll at least 30 patients in reference to previous similar studies using similar parenteral solution. Continuous variables were analysed using the paired t-test or Wilcoxon signed rank test.
MATERIALS AND METHODS

Patient selection
RESULTS
During a 5-month period, a total of 32 patients were enrolled. However, 2 patients failed to meet the inclusion criteria and failed the screening test as well. As a result, 30 patients completed the study and were included in the full analysis set. Mean age was 57.23±10.77 and male to female ratio was 2 to 1 ( Table 1) . Most patients underwent surgery due to malignant disease. Liver resection was the most common operation performed (43.3%) ( Table 1 ).
There was a significant decrease in serum prealbumin and CK on the third postoperative day (p＜0.0001). Although not significant, serum transferrin levels tended to decrease (p=0.0519) (Fig. 2) . During the study period, patient vital signs, physical examination and laboratory results revealed no adverse effects. Also, there was no mortality case.
DISCUSSION
Metabolic alterations of hepatobiliary disease are characterized by hyperdynamic changes, hypermetabolism, and catabolism. Hyperdynamic changes raise energy expenditure through increasing cardiac output and activation of the sympathetic nervous system, decreasing systemic vascular resistance, and so on. and prolongs survival. 17 However, postoperative total enteral feeding is associated with complications such as diarrhea, abdominal distention, and abdominal cramps.
These symptoms worsen with increasing caloric intake and can lead to discontinuance of enteral feeding. Nutritional treatment strategy accepted by majority practitioners is that EN support should be actively applied, if the gastrointestinal anatomy and function allows. Otherwise However, parenteral nutrition can be complicated by many metabolic problems, which may arise from inadequate or excessive amounts, or from inappropriate composition of nutrients. The most severe complications are cholestatic liver disease and bone disease. 19 Also catheter-related and infectious complications can occur. 19 In our study, there were no complications in patients receiving PN partially because of peripheral administration of PN.
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